Robot helper for heart valve surgery? new device tested in 158 patients

NCT ID NCT07392359

Not yet recruiting Disease control Sponsor: Zhicheng Medical Technology (Jiaxing) Co, Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the TAVR Assist System, which helps doctors perform a heart valve replacement procedure (TAVR) for severe aortic stenosis. The trial will compare the assist system to the standard manual TAVR in 158 older adults. The goal is to see if the device is as safe and effective as the usual approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TAVR Assist System (a device used during heart valve replacement)
What this could lead to: If successful, this device could make TAVR procedures more consistent and potentially safer for patients with severe aortic stenosis.
What could go wrong: This is an early-stage, non-inferiority trial with only 158 participants. The device may not prove to be as good as manual TAVR, and there are always risks with any heart procedure, such as bleeding or valve problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS TREATED WITH TAVI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC STENOSIS TREATED WITH TAVI

More trials for these conditions

Other studies related to the condition(s) this trial covers.